本页面由Tiger Trade Technology Pte. Ltd.提供服务

Magenta Therapeutics Inc.

11.19
0.0000
成交量:- -
成交额:26.88万
市值:4,224.34万
市盈率:-0.61
高:11.19
开:11.19
低:11.19
收:11.19
52周最高:35.49
52周最低:5.14
股本:377.39万
流通股本:210.24万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-18.2297
每股收益(LYR):-20.6054
净资产收益率:-65.34%
总资产收益率:-28.85%
市净率:0.57
市盈率(LYR):-0.54

数据加载中...

2023/09/22

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/01

SEC问询函

Form CORRESP - Correspondence
2023/07/17

SEC问询函

Form CORRESP - Correspondence
2023/06/23

SEC问询函

Form CORRESP - Correspondence
2023/05/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/05/19

重要事件披露

Form 8-K - Current report
2023/05/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/03

重要事件披露

8-K - Current report
2023/05/03

企业合并公告

425 - Prospectuses and communications, business combinations
2023/05/01

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]